Publications

Filters: Biosimilar medicines
x
policy
x
Newsroom

Twitter

Videos

Photos

20160128 EGA Regulatory and Scientific Affairs Conferenc

Call for tenders SANTE/2020/C3/29 for the supply of medicinal products used for intensive care patients subject to the novel coronavirus (COVID-19) disease – policy and technical concerns

25 June 2020

Policy

Read More

Preparing for a potential second COVID-19 wave. Joint statement by Medicines for Europe and EFPIA with Kearney

22 June 2020

Policy

Read More

LESSONS LEARNED FROM COVID-19 – POLICY PAPER

22 June 2020

Policy

Read More

Open letter to the Members of the European Parliament on the importance to sustain EU progress in fighting against antimicrobial resistance (AMR)

11 September 2019

Policy

Read More

Medicines for Europe Commentary on the Draft EMA regulatory science strategy 2025

28 June 2019

Policy

Read More

Medicines For Europe Country Specific Market Access Policies

24 May 2018

Policy

Read More

Position paper on Best Procurement Practices

28 April 2018

Policy

Read More

IGBA position on identification of biological, including biosimilar medicines (2018 update of facts & figures)

20 April 2018

Policy

Read More

Life Science Industry Coalition Position paper

14 December 2017

Policy

Read More

Position Paper: for an ambitious EU industrial strategy

24 October 2017

Policy

Read More

Subscribe to our newsletter




    Medicines For Europe